5 AM Ventures is both a seed as well as an early stage fund that goes for making and creating biotechnology organizations. This fund is typically supported by two among the top life science speculation organizations, Versant Ventures and Bay City Capital. They are overseeing more than $1 billion for the store. It was in the year 2003 when it was declared that the store had retained Scott M. Rocklage Ph.D. as the venture partner with them. Rocklage has been the CEO of Cubist Pharmaceuticals, Inc. since 1994 where he directed its advancement and the endorsement of Cubicin by the FDA to end up distinctly an anti-infection and antibiotic driven treatment. He was additionally required in the advancement of two other pharmaceutical items that were endorsed by FDA while working at Nycomed Salutar, Inc. as a CEO. Scott Rocklage is relied upon to consolidate endeavors with three other investment experts at 5AM Ventures, Andy Schwab, John Diekman and Carin Mueller. The three established the firm in the year 2002.
Scott Rocklage is a Venture Partner with 5AM Ventures, having had over three long decades of experience in healthcare management and leadership roles that contributed to the FDA’s approval of 3 New Drug Applications for the United States namely Teslascan, Omniscan, and Cubicin. Rocklage has previously been Chairman and CEO of Cubist Pharmaceuticals, CEO, and president of Nycomed Salutar and has likewise held R&D positions at Salutar and Catalytica. He as of now works as the Board Chairman at Cidara, Kinestral, and Rennovia (CDTX: NASDAQ) and also on the Boards Pulmatrix (PULM: NASDAQb) and Epirus (EPRS: NASDAQ). Dr. Rocklage was some time ago elected the Ilypsa Executive Chairman (obtained by Amgen), Miikana (procured by EntreMed) and Semprus (gained by Teleflex). Dr. Rocklage got his B.S. in Chemistry from the University of California, Berkeley and his Ph.D. in Chemistry which he finished at MIT, where he oversaw research in the lab of Richard R. Schrock, a Nobel Prize winner in Chemistry. He is a designer or co-creator of more than 30 U.S. licenses and has more than 100 associate evaluated productions. Dr. Rocklage is situated in the Boston, MA office.